AI assistant
Health Catalyst, Inc. — Director's Dealing 2021
Apr 9, 2021
33681_dirs_2021-04-08_058ab480-213d-46e1-8679-afb204b561db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-04-05
Reporting Person: Horstmeier Paul (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-05 | Common Stock | S | 5800.00 | $48.0907 | Disposed | 118902.00 | Direct |
Footnotes
F1: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1.
F2: Represents the weighted average sale price of the shares sold ranging from $47.63 to $48.58 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.